MRI The Appy | Tazo or Cefepime

The JournalFeed podcast for the week of Oct 30 Nov 3, 2023.

These are summaries from just 2 of the 5 article we cover every week! For access to more, please visit JournalFeed.org for details about becoming a member.

Tuesday Spoon Feed:

After a non-diagnostic screening ultrasound for appendicitis, a rapid-MRI has high clinical accuracy in establishing the appropriate diagnosis (appendicitis or not) in a pediatric patient population.

Friday Spoon Feed:

In this randomized control trial (RCT) of patients receiving cefepime or piperacillin-tazobactam, there was no difference in risk of acute kidney injury (AKI) between the two groups. However, those who received cefepime were more likely to have neurologic side effects.